Anavex Life Sciences Corp (AVXL)

[kevindenver]

Glad to see Anavex is actively engaging the Rett community, academics, and the regulatory agencies to achieve consensus and agreement.

This paper is a further demonstration of Anavex’s involvement as part of the team of clinicians and commitment to the rare disease and especially to the Rett syndrome community,” said Christopher U Missling, PhD, President and Chief Executive Officer of Anavex. "We are looking forward to the topline data from the EXCELLENCE Phase 2/3 ANAVEX®2-73-RS-003 Rett syndrome pediatric clinical trial in the second half of 2023.”